BioSpace News Archive

Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans

Collaborations with Veterans Health Administration, CVS Health and NAFC focused on health disparities in underserved communities

Reata Pharmaceuticals, Inc. today announced that management will participate in a virtual Fireside chat and hold 1x1 meetings at the Goldman Sachs 42nd Annual Global Healthcare Conference

On behalf of those impacted by Alzheimer’s disease, the Alzheimer’s Association enthusiastically welcomes today’s historic FDA approval of aducanumab (Biogen/Eisai) for treatment of Alzheimer’s disease.

The Alzheimer Society of Canada is hopeful about the U.S. Food and Drug Administration’s (FDA) approval of aducanumab, a new treatment for Alzheimer’s disease.

Increasing vaccine confidence is a critical part of getting through the COVID-19 pandemic. As COVID-19 vaccines roll out across the country, the Public Health Agency of Canada is supporting community-driven information initiatives through its Vaccine Community Innovation Challenge.

Flavocure is a clinical stage ready company, and its first drug candidate targets pancreatic adenocarcinoma which is currently uncurable.

GenesisCare—one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom—today announced the appointment of Bridget F. Koontz, MD, to the position of U.S. Chief Medical Officer (CMO) - Deputy Group CMO, and Neal D. Shore, MD, FACS to the position of U.S. Chief Medical Officer (CMO) of Surgery and Urology.

Pursuant to the subscription right exercise program of Galapagos’ management board, members of the management board automatically are committed to exercise a minimum number of subscription rights, subject to certain conditions.

HealthEquity, Inc., the nation’s largest health savings account non-bank custodian, announced financial results for its first quarter ended April 30, 2021.